miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.

Abstract

These findings suggested that miR-221 play an oncogenic role in the renal cancer cell proliferation, migration and invasion by directly inhibiting the tumor suppressor TIMP2, indicating miR-221 act as a potential new therapeutic target for the treatment of ccRCC.